Psychemedics PMD Stock
Psychemedics Price Chart
Psychemedics PMD Financial and Trading Overview
| Psychemedics stock price | 2.67 USD |
| Previous Close | 4.66 USD |
| Open | 4.69 USD |
| Bid | 0 USD x 1400 |
| Ask | 0 USD x 1100 |
| Day's Range | 4.65 - 4.74 USD |
| 52 Week Range | 4.56 - 6.94 USD |
| Volume | 15.68K USD |
| Avg. Volume | 9.4K USD |
| Market Cap | 26.6M USD |
| Beta (5Y Monthly) | 0.623239 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | 0.28 (6.01%) |
| Ex-Dividend Date | May 24, 2023 |
| 1y Target Est | N/A |
PMD Valuation Measures
| Enterprise Value | 25.6M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.0818326 |
| Price/Book (mrq) | 2.6006713 |
| Enterprise Value/Revenue | 1.041 |
| Enterprise Value/EBITDA | -16.768 |
Trading Information
Psychemedics Stock Price History
| Beta (5Y Monthly) | 0.623239 |
| 52-Week Change | -25.59% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 6.94 USD |
| 52 Week Low | 4.56 USD |
| 50-Day Moving Average | 5.13 USD |
| 200-Day Moving Average | 5.66 USD |
PMD Share Statistics
| Avg. Volume (3 month) | 9.4K USD |
| Avg. Daily Volume (10-Days) | 20.51K USD |
| Shares Outstanding | 5.72M |
| Float | 4.58M |
| Short Ratio | 1.96 |
| % Held by Insiders | 19.92% |
| % Held by Institutions | 25.81% |
| Shares Short | 12.3K |
| Short % of Float | 0.27% |
| Short % of Shares Outstanding | 0.20% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0.28 |
| Trailing Annual Dividend Yield | 6.00% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | 1:4 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -6.12% |
| Operating Margin (ttm) | -13.83% |
| Gross Margin | 29.50% |
| EBITDA Margin | -6.20% |
Management Effectiveness
| Return on Assets (ttm) | -10.93% |
| Return on Equity (ttm) | -13.31% |
Income Statement
| Revenue (ttm) | 24.59M USD |
| Revenue Per Share (ttm) | 4.35 USD |
| Quarterly Revenue Growth (yoy) | -10.00000000000000000000000000000000% |
| Gross Profit (ttm) | N/A |
| EBITDA | -1527000 USD |
| Net Income Avi to Common (ttm) | -1507000 USD |
| Diluted EPS (ttm) | -0.27 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 4.38M USD |
| Total Cash Per Share (mrq) | 0.77 USD |
| Total Debt (mrq) | 3.32M USD |
| Total Debt/Equity (mrq) | 32.7 USD |
| Current Ratio (mrq) | 1.647 |
| Book Value Per Share (mrq) | 1.788 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 4.32M USD |
| Levered Free Cash Flow (ttm) | 5.6M USD |
Profile of Psychemedics
| Country | United States |
| State | MA |
| City | Acton |
| Address | 289 Great Road |
| ZIP | 01720 |
| Phone | 978 206 8220 |
| Website | https://www.psychemedics.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 133 |
Psychemedics Corporation provides testing services for the detection of drugs of abuse through the analysis of hair samples in the United States and internationally. The company offers screening and confirmation by mass spectrometry using industry-accepted practices for cocaine, marijuana, and PCP; amphetamines, including ecstasy, eve, and Adderall; opiates, such as heroin, hydrocodone, hydromorphone, oxycodone, oxymorphone, and codeine; synthetic cannabinoids comprising K2, Spice, and Blaze; benzodiazepines consisting of Xanax, Valium, and Ativan; and nicotine, Fentanyl, and alcohol. Its testing results provide quantitative information that could indicate the approximate amount of drug ingested, as well as historical data that could show a pattern of individual drug use over a longer period-of-time. The company offers its services to employers for applicant and employee testing; and treatment professionals, law enforcement agencies, school administrators, and parents concerned about their children's drug use. Psychemedics Corporation was incorporated in 1986 and is headquartered in Acton, Massachusetts.
Q&A For Psychemedics Stock
What is a current PMD stock price?
Psychemedics PMD stock price today per share is 2.67 USD.
How to purchase Psychemedics stock?
You can buy PMD shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Psychemedics?
The stock symbol or ticker of Psychemedics is PMD.
Which industry does the Psychemedics company belong to?
The Psychemedics industry is Diagnostics & Research.
How many shares does Psychemedics have in circulation?
The max supply of Psychemedics shares is 0.
What is Psychemedics Price to Earnings Ratio (PE Ratio)?
Psychemedics PE Ratio is now.
What was Psychemedics earnings per share over the trailing 12 months (TTM)?
Psychemedics EPS is 0 USD over the trailing 12 months.
Which sector does the Psychemedics company belong to?
The Psychemedics sector is Healthcare.
Psychemedics PMD included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 17382.94 USD — |
+1.26
|
6.5B USD — | 17110.72 USD — | 17404.49 USD — | — - | 6.5B USD — |
| NASDAQ Composite Total Return I XCMP | 21278.67 USD — |
+1.26
|
— — | 20945.45 USD — | 21305.05 USD — | — - | — — |
| NASDAQ Capital Market Composite RCMP | 102.15 USD — |
-0.54
|
— — | 101.35 USD — | 102.39 USD — | — - | — — |
| NASDAQ HealthCare IXHC | 923.51 USD — |
-0.73
|
— — | 917.75 USD — | 925.61 USD — | — - | — — |
- {{ link.label }} {{link}}